Navigation Links
Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
Date:11/3/2009

TUSTIN, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that on November 3, 2009, the Company received notice from the NASDAQ Market Listing Qualifications Department stating that it has regained compliance with the minimum bid price rule for the continued listing of its common stock on the NASDAQ Capital Market, as set forth in NASDAQ Marketplace Rule 5550(a)(2).

Pursuant to NASDAQ's rules, Peregrine was required to evidence a closing bid price of at least $1.00 per share for 10 consecutive trading days. The letter received from NASDAQ confirms that this requirement has been met and that Peregrine is now in full compliance with all NASDAQ continued listing requirements. As a result, Peregrine's shares will continue to trade on the NASDAQ Capital Market.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, pl
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) t...affray 21st Annual Health Care Conference on Wedne...rs may access a live webcast of the presentation a...nload any necessary software, please log on 10 min...inceton, New Jersey, is one of the world,s largest...
(Date:11/30/2009)...RNewswire/ -- The Eleventh Annual Southeastern BIO... Charleston Place Hotel in the historic district o...yl Liljestrand, Dr. Harry Guttman, and Dr. Jeremy ...ill attend. SEBIO 2009 promises to bring innovati...entrepreneurs, and service providers from around t...
(Date:11/30/2009)...swire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: ...ts and services, announced today that Steven Palad...ief Financial Officer, will present at the NASDAQ ...2009. The conference is taking place at the Mayfa...tion is scheduled to begin at 9:15 a.m. EST and ca...
Breaking Medicine Technology:Henry Schein to Present at the NASDAQ OMX 23rd Investor Program 2Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 1Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 2Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 3Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 4Commercial Insurance Buyers Benefit From Ample Capacity 14306 1Commercial Insurance Buyers Benefit From Ample Capacity 14306 2Commercial Insurance Buyers Benefit From Ample Capacity 14306 3Cardiac stem cell trial seeks to treat some heart attack patients 58592 1Cardiac stem cell trial seeks to treat some heart attack patients 58592 2Cardiac stem cell trial seeks to treat some heart attack patients 58592 3
(Date:12/1/2009)...und with elastography can help differentiate betwe... to a study presented today at the annual meeting ...). , "High-frequency ultrasound with elastograph...kin cancer diagnosis," said lead author Eliot L. S...diology at the University of Maryland School of Me...
(Date:12/1/2009)...d, controlled clinical trial presented today at th...rth America (RSNA) reveal that one in five patient...ly blood to the legs and other parts of the body a...sease. , Peripheral arterial disease (PAD) occu...and other substances, builds up in the arteries, l...
(Date:12/1/2009)... Adolescent obesity is a major public health prob...resulting in 4-5 million overweight youth in the U... 2009 issue of the Journal of the American Dietet... in weight control behaviors, including dietary in...dolescents who lost weight and those who did not i...
(Date:11/30/2009)...ast Fertility is attempting to dispel the notion t...and send patients home pregnant with multiples. W...ent, their priority is health and safety. In addi...hs can put on a country’s healthcare system...., 2009 -- Many patients and doctors in the U.K. wo...
(Date:11/30/2009)...wswire/ -- Results of a randomized, controlled cli...of the Radiological Society of North America (RSNA...or blockage in arteries that supply blood to the l...ant but silent coronary artery disease. ,, Per... a combination of fat, cholesterol and other subst...
Breaking Medicine News(10 mins):Health News:Special ultrasound accurately identifies skin cancer 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:Investigators identify successful weight control strategies for adolescents 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3
...who is president-elect of the Chicago Medical Soci...d work with lawmakers in the US on healthcare// re...be paid in cases of medical negligence. Shastr...e 3. Foremost on his agenda, he said, would ...
...eader Pramod Mahajan underwent a minor surgery on ...k after being shot at by his brother//. Doctors...olitician was rushed April 22 after Pravin Mahajan...r and a BJP general secretary, underwent a minor s...
...K has found that care home fees has increased by o... But in the concurrent period basic state pension ...said that the care home fees is bound to jump by a... capital above a certain limit get no help for the...
...(EMEA) has recommended the use of breast cancer dr...cord 27 days review//. A license for the drug is t... Institute of Health and Clinical Excellence in th...l be able to issue national guidance to the NHS on...
...called the Acomplia which the European Medicines A... for weight loss//. After this its shares rose 2.7...proved the drug for weight control. The chemical n...ommittee and FDA to make Acomplia available as an ...
...ultry from UK to prevent the spread of bird flu to...said in statement// as soon as the British ministr...ain of bird flu. This virus is less dangerous ...being spotted on another farm nearby in the easter...
Other Medicine News:Health News:Indian American Doctor Wants Healthcare Reforms 2Health News:Pramod Mahajan Undergoes Third Surgery 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: